These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10918410

  • 1. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.
    Bönig H, Laws HJ, Wundes A, Verheyen J, Hannen M, Kim YM, Banning U, Nürnberger W, Körholz D.
    Bone Marrow Transplant; 2000 Jul; 26(1):91-6. PubMed ID: 10918410
    [Abstract] [Full Text] [Related]

  • 2. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
    Chan KW, Petropoulos D, Choroszy M, Herzog C, Jaffe N, Ater J, Korbling M.
    Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
    [Abstract] [Full Text] [Related]

  • 3. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B, Tröger A, Glouchkova L, Körholz D, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Dec; 216(3):176-82. PubMed ID: 15175963
    [Abstract] [Full Text] [Related]

  • 4. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [Abstract] [Full Text] [Related]

  • 5. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors.
    Pérez-Martínez A, Leung W, Muñoz E, Iyengar R, Ramírez M, Vicario JL, Lassaletta A, Sevilla J, González-Vicent M, Madero L, Díaz-Pérez MA.
    Pediatr Blood Cancer; 2009 Jul; 53(1):120-4. PubMed ID: 19215002
    [Abstract] [Full Text] [Related]

  • 6. Biology and treatment of pediatric malignant solid tumors.
    Marina NM.
    Cancer Chemother Biol Response Modif; 1997 Jul; 17():642-71. PubMed ID: 9551234
    [No Abstract] [Full Text] [Related]

  • 7. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
    Yonemoto T, Tatezaki S, Ishii T, Satoh T.
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
    [Abstract] [Full Text] [Related]

  • 8. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
    Drabko K, Zawitkowska-Klaczynska J, Wojcik B, Choma M, Zaucha-Prazmo A, Kowalczyk J, Gorczynska E, Toporski J, Kałwak K, Turkiewicz D, Chybicka A.
    Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
    [Abstract] [Full Text] [Related]

  • 9. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A, Chow WA, Valdes F, Leong L, Phan V, Twardowski P, Kapoor N, Molina A, Al-Kadhimi Z, Frankel P, Somlo G.
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [Abstract] [Full Text] [Related]

  • 10. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
    Lang P, Pfeiffer M, Müller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, Föll J, Martin D, Handgretinger R.
    Klin Padiatr; 2006 Aug; 218(6):321-6. PubMed ID: 17080334
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
    Suminoe A, Matsuzaki A, Hattori H, Koga Y, Hara T.
    Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
    [Abstract] [Full Text] [Related]

  • 12. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 13. Induction of two distinct natural killer-cell populations, activated T cells and antineoplastic cytokines, by interleukin-2 therapy in children with solid tumors.
    Dilloo D, Laws HJ, Hanenberg H, Körholz D, Nürnberger W, Burdach SE.
    Exp Hematol; 1994 Oct 15; 22(11):1081-8. PubMed ID: 7925775
    [Abstract] [Full Text] [Related]

  • 14. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE.
    Int Immunopharmacol; 2003 Aug 15; 3(8):1121-43. PubMed ID: 12860168
    [Abstract] [Full Text] [Related]

  • 15. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J, Garkavij M, Tennvall J, Ora I, Gleisner KS, Dykes JH, Lenhoff S, Juliusson G, Scheding S, Turkiewicz D, Békássy AN.
    Biol Blood Marrow Transplant; 2009 Sep 15; 15(9):1077-85. PubMed ID: 19660720
    [Abstract] [Full Text] [Related]

  • 16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 17. Phase I-II study of interleukin-2 after high-dose chemotherapy and autologous bone marrow transplantation in poorly responding neuroblastoma.
    Valteau-Couanet D, Rubie H, Meresse V, Farace F, Brandely M, Hartmann O.
    Bone Marrow Transplant; 1995 Oct 15; 16(4):515-20. PubMed ID: 8528166
    [Abstract] [Full Text] [Related]

  • 18. Biology and therapy of pediatric malignant solid tumors.
    Marina N.
    Cancer Chemother Biol Response Modif; 1999 Oct 15; 18():550-89. PubMed ID: 10800501
    [No Abstract] [Full Text] [Related]

  • 19. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

  • 20. Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.
    Staege MS, Hansen G, Baersch G, Burdach S.
    Pediatr Blood Cancer; 2004 Jul 15; 43(1):23-34. PubMed ID: 15170886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.